DEFA14A: Dow Inc. Corrects TSR Calculation in Proxy Statement Supplement
Proxy Statement Supplement
Dow Inc. files a supplement to its 2024 proxy statement to correct an administrative error in the calculation of the S&P 500 Chemicals Index cumulative TSR returns for 2022 and 2023.
Summary
- Dow Inc. has issued a supplement to its definitive proxy statement filed on March 1, 2024.
- The supplement, dated March 5, 2024, addresses an error in the calculation of the S&P 500 Chemicals Index cumulative TSR returns for 2022 and 2023.
- The error was located in the TSR chart within the Pay Versus Performance disclosure on page 91 of the original proxy statement.
- The supplement replaces the incorrect TSR chart with a corrected version.
- All other information in the original proxy statement remains unchanged, unless specifically revised by the supplement.
- The supplement does not reflect events occurring after the date of the original proxy statement.
Sentiment
Score: 7
Explanation: The document is a routine correction of an administrative error, which is a neutral event. The company is taking steps to ensure accuracy, which is a positive sign.
Negatives
- An administrative error was identified in the original proxy statement regarding the calculation of the S&P 500 Chemicals Index cumulative TSR returns.
Future Outlook
The supplement does not provide any forward-looking statements beyond the correction of the TSR calculation.
Industry Context
The correction of the TSR calculation ensures accurate reporting of company performance relative to its peers in the S&P 500 Chemicals Index, which is important for investor confidence and executive compensation decisions.
Stakeholder Impact
- The correction ensures that shareholders have accurate information regarding the company's performance relative to its peers.
Key Dates
| Date | Description |
|---|---|
| 2024-03-01 | Original definitive proxy statement filed with the SEC. |
| 2024-03-05 | Date of the proxy statement supplement. |
| 2024-04-11 | Annual meeting of stockholders. |
Keywords
Proxy Statement, TSR, Dow Inc., Supplement, Pay Versus Performance, S&P 500 Chemicals Index, Annual Meeting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.